Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5
Arena Pharmaceuticals (Nasdaq: ARNA) will announce its first quarter 2021 financial results and corporate update on May 5, 2021, after U.S. market close. The company will hold a conference call at 4:30 PM ET for investors, providing a platform for questions and discussion. Participants are encouraged to join 20 minutes early for registration. Arena Pharmaceuticals is committed to delivering essential medicines and has emphasized its focus on executing disruptive ideas in the healthcare sector.
- None.
- None.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2021 financial results and provide a corporate update on Wednesday, May 5, 2021, after the close of the U.S. financial markets. The Company will host a question and answer session via conference call and live webcast with the investment community the same day at 4:30 PM ET.
Conference Call & Webcast Information
When: Wednesday, May 5, 2021, at 4:30 PM ET
Dial-in: (877) 643-7155 (United States) or (914) 495-8552 (International)
Conference ID: 4329177
Please join the conference call at least 20 minutes early to register. You can access the live webcast under the investor relations section of Arena's website. A replay of the conference call will be archived for 30 days after the call.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose – deliver important medicines to patients.
In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get medicines to patients, and relentlessly execute until it’s done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's position, drive, portfolio, prioritization, financial position, team, and building of the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005002/en/
FAQ
What date will Arena Pharmaceuticals release its Q1 2021 financial results?
What time is the conference call for Arena Pharmaceuticals' Q1 results?
How can I access the webcast for Arena Pharmaceuticals' Q1 2021 financial results?
What is Arena Pharmaceuticals' stock symbol?
